W
WAVEMAN · COMPANY
QCLS · Q/C Technologies, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

QCLS

Q/C TECHNOLOGIES, INC.
PHARMA & BIOTECH · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · CIK 0001321834
SEC FILINGS☆ WATCH
INSIDER NET · 180D
$5.5K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
12
13F, latest reported quarter
REVENUE GROWTH
-5.3%
XBRL, annual
NET MARGIN
-737.3%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$5.5K over 180 days
more than 67% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
12 funds added or opened last quarter
below 79% of Pharma & Biotech
REVENUE
-5.3% year over year
below 65% of Pharma & Biotech
MARGIN
-737.3% net margin
below 86% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -52.9%
-52.9%12M
-53%-8%+37%+82%2025-092025-102025-122026-032026-052026-072026-09 2026-03-30 · Voss Chelsea Sierra bought $5.5K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders are net buyers of their own stock.
The record shows a net $5.5K bought by insiders over 180 days, 12 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Q/C TECHNOLOGIES, INC. insiders bought a net $5.5K of stock across 1 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Voss Chelsea Sierra
Director
BUY
2026-03-30
1,753.0
$5.5K
1 TRANSACTION ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Quinn Opportunity Partners LLC
123,024.0 sh
$479.8K
VANGUARD CAPITAL MANAGEMENT LLC
115,031.0 sh
$448.6K
JANE STREET GROUP, LLC
87,241.0 sh
$340.2K
GEODE CAPITAL MANAGEMENT, LLC
70,682.0 sh
$275.7K
UBS Group AG
58,894.0 sh
$229.7K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
U.S. SMALL CAP PORTFOLIO
$49.5K POSITION · AS OF 2026-04-30
0.0%
Fidelity Extended Market Index Fund
$72.7K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$129.4K POSITION · AS OF 2026-03-31
0.0%
Dimensional U.S. Small Cap ETF
$20.9K POSITION · AS OF 2026-04-30
0.0%
Dimensional US Core Equity 1 ETF
$1.1K POSITION · AS OF 2026-04-30
0.0%
Fidelity Series Total Market Index Fund
$18.9K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
OPERATING INCOME$-9.8M$-10.2M$-17.1M$-15.3M
NET INCOME$-11.6M$-23.4M$-4.0M$-15.2M
EPS (DILUTED)-8.66-1,080.87-5.33-11.74
OPERATING CASH FLOW$-9.1M$-9.0M$-13.0M$-12.3M
CASH$987.0K$173.2K$2.7M$749.1K
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →